blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0980866

EP0980866 - Phenyl heterocycles as cyclooxygenase-2 inhibitors [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.05.2008
Database last updated on 15.07.2024
Most recent event   Tooltip23.05.2008Application deemed to be withdrawnpublished on 25.06.2008  [2008/26]
Applicant(s)For all designated states
Merck Frosst Company
16711 Trans-Canada Highway
Kirkland, Québec H9H 3L1 / CA
[2006/40]
Former [2000/08]For all designated states
Merck Frosst Canada & Co.
Purdy's Wharf Tower One, 1959 upper Water Street, P.O. Box 997
Halifax, Nova Scotia B3J 2X2 / CA
Inventor(s)01 / Ducharme, Yves
4194 Harvard
Montreal, Quebec H4A 2W7 / CA
02 / Leblanc, Yves
8 Lafford
Kirkland, Quebec H9J 3Y3 / CA
03 / Gauthier, Jacques Yves
540 Odette Oligny, Apt. 2
Laval, Quebec H7N 5Z4 / CA
04 / Wang, Zhaoyin
13199 Edison Crescent
Pierrefonds, Quebec H8Z 1Y5 / CA
05 / Prasit, Petpiboon
177 Argyle Drive
Kirkland, Quebec H9H 5A6 / CA
06 / Leger, Serge
51 Lamarche
Dollard des Ormeaux, Quebec H9B 3E5 / CA
07 / Therien, Michel
944 21st Avenue
Laval, Quebec H7R 2R2 / CA
[2000/08]
Representative(s)Horgan, James Michael Frederic, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2006/49]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Former [2004/27]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Former [2000/08]Cole, William Gwyn, et al
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date99202239.209.06.1994
[2000/08]
Priority number, dateUS1993008219624.06.1993         Original published format: US 82196
US1994017946710.01.1994         Original published format: US 179467
[2000/08]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0980866
Date:23.02.2000
Language:EN
[2000/08]
Type: A3 Search report 
No.:EP0980866
Date:08.03.2000
[2000/10]
Search report(s)(Supplementary) European search report - dispatched on:EP19.01.2000
ClassificationIPC:C07D307/58, A61K31/33, C07D275/02, C07D307/38, C07D333/18, C07D277/26, C07C311/29
[2000/08]
CPC:
C07D275/02 (EP,US); A61P1/00 (EP); A61P1/02 (EP);
A61P1/04 (EP); A61P11/06 (EP); A61P15/00 (EP);
A61P17/02 (EP); A61P19/00 (EP); A61P19/02 (EP);
A61P21/00 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P31/12 (EP); A61P31/16 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P7/04 (EP); C07C311/29 (EP,US);
C07C311/46 (EP,US); C07C311/49 (EP,US); C07C317/24 (EP,US);
C07D277/26 (EP,US); C07D307/38 (EP,US); C07D307/58 (EP,US);
C07D333/18 (EP,US); C07D333/38 (EP,US); C07D405/04 (EP,US);
C07C2601/08 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2000/08]
Extension statesSI09.08.1999
TitleGerman:Phenyl-heterocyclen als Cyclooxygenase-2 Inhibitoren[2000/08]
English:Phenyl heterocycles as cyclooxygenase-2 inhibitors[2000/08]
French:Phenyl hétérocycles et leur utilisation comme inhibiteurs de cyclooxygénase-2[2000/08]
Examination procedure08.09.2000Examination requested  [2000/45]
29.05.2007Despatch of a communication from the examining division (Time limit: M06)
11.12.2007Application deemed to be withdrawn, date of legal effect  [2008/26]
07.02.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/26]
Parent application(s)   TooltipEP94918259.6  / EP0705254
EP96202573.0  / EP0754687
Fees paidRenewal fee
09.11.1999Renewal fee patent year 03
09.11.1999Renewal fee patent year 04
09.11.1999Renewal fee patent year 05
09.11.1999Renewal fee patent year 06
30.06.2000Renewal fee patent year 07
02.07.2001Renewal fee patent year 08
01.07.2002Renewal fee patent year 09
04.06.2003Renewal fee patent year 10
04.06.2004Renewal fee patent year 11
06.06.2005Renewal fee patent year 12
27.03.2006Renewal fee patent year 13
08.06.2007Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]EP0087629  (DU PONT [US]) [Y] 1-33 * see pages 13-14; page 8; table I *;
 [Y]EP0388909  (FUJISAWA PHARMACEUTICAL CO [JP]) [Y] 1-33* see claim 1; page 9 - page 11; table I *;
 [X]WO9119708  (FUJISAWA PHARMACEUTICAL CO [JP]) [X] 1-33 * see examples *;
 [EX]WO9415932  (SEARLE & CO [US], et al) [E] 1-33 * see example 13 * * see scheme IV, compound 15, p. 32 ; see example 13, step 4 * [X] 23,1-22,24-33;
 [Y]  - CHEMICAL ABSTRACTS, (19901119), vol. 113, no. 21, Database accession no. 184393m, page 33, XP002048246 [Y] 1-33
    [ ] - GANS,K; GALBRAITH,W; ROMAN R. ET AL., "Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor", J. PHARMACOL. EXP. THER., (1990), vol. 254, no. 1, pages 180 - 187 [ ] * see abstract *; page 8; table I *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.